Hepatic Responses to Acetaminophen Challenge in SelenBP1-Deficient Mice
6 affiliations
- 1Laboratory of Molecular Life Sciences, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan
- 2Division of Pharmaceutical Cell Biology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka 812-8582, Japan
- 3Shanghai Lu Daopei Hematology Hospital, Shanghai 201114, China
- 4School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 211198, China
- 5Faculty of Pharmaceutical Sciences, International University of Health and Welfare, Fukuoka 812-8582 Japan
- 6Department of Pharmaceutical Sciences, Daiichi University of Pharmacy, 22-1 Tamagawa-cho, Minami-ku, Fukuoka 815-8511, Japan
Abstract
Background/Objectives: Selenium-binding protein 1 (SelenBP1) has been identified as a target protein for covalent binding of N-acetyl-p-benzoquinone imine (NAPQI), the reactive metabolite of acetaminophen (APAP). However, its contribution to APAP-induced hepatotoxicity remains unclear. In the present study, we evaluated the hepatic response to APAP challenge in male SelenBP1-deficient mice. Methods: Male SelenBP1(−/−) and SelenBP1(+/+) mice were fasted for 20 h and treated with APAP (200 mg/kg, i.p.). Hepatic SelenBP1 and SelenBP2 expression levels were evaluated by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting. Notably, the antibody could not discriminate between the SelenBP1 and SelenBP2 bands in wild-type male liver samples; therefore, Western blot data represent the combined total of SelenBP1 and SelenBP2 proteins. Liver injury was assessed using histopathology and serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities. Results: Hepatic SelenBP1 mRNA levels were markedly decreased in SelenBP1(+/+) mice following APAP treatment, whereas SelenBP2 mRNA expression was not further suppressed by APAP in either genotype. Histopathological examination revealed comparable centrilobular necrosis in both genotypes, and no significant differences were observed in serum ALT or AST activities. These findings indicated that there were no statistically significant differences in the measured liver injury parameters between wild-type and SelenBP1 knockout male mice. In addition, fasting induced distinct changes in total hepatic SelenBP1/SelenBP2 protein abundance in wild-type versus SelenBP1-deficient mice. Conclusions: No statistically significant differences in fasting-enhanced APAP-induced liver injury were observed between wild-type and SelenBP1 knockout male mice. Altered total hepatic SelenBP1/SelenBP2 protein levels in SelenBP1-deficient mice were an observational finding; a potential compensatory mechanism remains an unverified hypothesis requiring further investigation.
Related
- Lipid-Driven NRF2 Preconditioning Links Estrogen Deprivation to Hepatic Resilience Against Acetaminophen Injury
- SMARCB1/INI1-deficient Undifferentiated Carcinoma Presenting as Cancer of Unknown Primary with Massive Hepatic Involvement: Transient Response to FOLFOX plus Nivolumab
- KDM4 inhibition alters H3K9me3 distribution and developmental responses in SETDB1-deficient embryonic stem cells
- Zebrafish Prdx1 is a redox-associated modulator of macrophage responses during bacterial challenge
- Molasses-Assisted Green Combustion Synthesis of LaFeO3 Perovskites: Structural and Interfacial Insights for the Simultaneous Electrochemical Determination of Acetaminophen and 4-Aminoantipyrine
BibTeX
@article{song2026hepatic,
title = {{Hepatic Responses to Acetaminophen Challenge in SelenBP1-Deficient Mice}},
author = {Yingxia Song and Shuangli Zhao and Atsushi Kurose and Yuko Onomura and Midori Yamamoto and Takumi Ishida and Tomoki Takeda and Takayuki Koga and Hideyuki Yamada and Yuji Ishii},
journal = {Metabolites},
year = {2026},
month = nov,
doi = {10.3390/metabo16110874},
url = {https://www.mdpi.com/2218-1989/16/11/874},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Hepatic Responses to Acetaminophen Challenge in SelenBP1-Deficient Mice
AU - Yingxia Song
AU - Shuangli Zhao
AU - Atsushi Kurose
AU - Yuko Onomura
AU - Midori Yamamoto
AU - Takumi Ishida
AU - Tomoki Takeda
AU - Takayuki Koga
AU - Hideyuki Yamada
AU - Yuji Ishii
PY - 2026
DA - 2026/11/10
JO - Metabolites
DO - 10.3390/metabo16110874
UR - https://www.mdpi.com/2218-1989/16/11/874
AB - Background/Objectives: Selenium-binding protein 1 (SelenBP1) has been identified as a target protein for covalent binding of N-acetyl-p-benzoquinone imine (NAPQI), the reactive metabolite of acetaminophen (APAP). However, its contribution to APAP-induced hepatotoxicity remains unclear. In the present study, we evaluated the hepatic response to APAP challenge in male SelenBP1-deficient mice. Methods: Male SelenBP1(−/−) and SelenBP1(+/+) mice were fasted for 20 h and treated with APAP (200 mg/kg, i.p.). Hepatic SelenBP1 and SelenBP2 expression levels were evaluated by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blotting. Notably, the antibody could not discriminate between the SelenBP1 and SelenBP2 bands in wild-type male liver samples; therefore, Western blot data represent the combined total of SelenBP1 and SelenBP2 proteins. Liver injury was assessed using histopathology and serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities. Results: Hepatic SelenBP1 mRNA levels were markedly decreased in SelenBP1(+/+) mice following APAP treatment, whereas SelenBP2 mRNA expression was not further suppressed by APAP in either genotype. Histopathological examination revealed comparable centrilobular necrosis in both genotypes, and no significant differences were observed in serum ALT or AST activities. These findings indicated that there were no statistically significant differences in the measured liver injury parameters between wild-type and SelenBP1 knockout male mice. In addition, fasting induced distinct changes in total hepatic SelenBP1/SelenBP2 protein abundance in wild-type versus SelenBP1-deficient mice. Conclusions: No statistically significant differences in fasting-enhanced APAP-induced liver injury were observed between wild-type and SelenBP1 knockout male mice. Altered total hepatic SelenBP1/SelenBP2 protein levels in SelenBP1-deficient mice were an observational finding; a potential compensatory mechanism remains an unverified hypothesis requiring further investigation.
SN - 2218-1989
ER -